Cited 0 times in
Linear Ablation Using a Contact Force-Sensing Catheter in Ablation for Persistent Atrial Fibrillation: A Prospective Randomized Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, DI | - |
dc.contributor.author | Lee, KN | - |
dc.contributor.author | Roh, SY | - |
dc.contributor.author | Kim, YG | - |
dc.contributor.author | Shim, J | - |
dc.contributor.author | Choi, JI | - |
dc.contributor.author | Kim, YH | - |
dc.date.accessioned | 2025-01-15T04:38:05Z | - |
dc.date.available | 2025-01-15T04:38:05Z | - |
dc.date.issued | 2024 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/33609 | - |
dc.description.abstract | Background/Objectives: Pulmonary vein isolation (PVI) using radiofrequency catheter ablation with contact force (CF)-sensing technology has improved long-term outcomes in patients with atrial fibrillation. This prospective randomized study aimed to assess the efficacy and safety of CF-sensing technology for additional left atrial (LA) linear ablation of persistent AF (PerAF). Methods: After PVI, anteromitral (AM) line and roof line ablation were performed using a CF-sensing catheter. Patients were randomly assigned to either the CF-sensing (CFS) group or the CF-blind control (Blind) group. The primary endpoint was atrial arrhythmia recurrence. LA late gadolinium enhancement (LA-LGE) MRI was conducted at baseline and 1-year follow-up for long-term lesion evaluation. Results: A total of 62 patients with drug-refractory PerAF were enrolled (mean age: 58 ± 10 years; 77% male). The success rates of AM and roof line block were 97% and 100% in the CFS group (n = 33) and 93% and 90% in the Blind group (n = 29). The time to achieve block was reduced in the CFS group (AM: 36 ± 22 vs. 48 ± 28 min, p = 0.068; roof: 19 ± 14 vs. 27 ± 15 min, p = 0.031). The maximum CF for safety endpoints was significantly lower in the CFS group (AM: 42 vs. 69 g, p < 0.001; roof: 33 vs. 49 g, p = 0.003). Full linear LA-LGE formation on 1-year MRI did not differ significantly between the groups (AM: 17 vs. 36%; roof; 29 vs. 24%, both p = NS). Kaplan–Meier estimates of AF/AT-free survival after ablation procedures were 63.6% in the CFS group and 58.6% in the Blind group (log-rank p = 0.837). Conclusions: In patients with PerAF, additional LA linear ablation following PVI using CF-sensing technology improved procedural safety and reduced the time needed to achieve conduction block. However, it did not significantly influence clinical outcomes or the formation of permanent full linear lesions. | - |
dc.language.iso | en | - |
dc.title | Linear Ablation Using a Contact Force-Sensing Catheter in Ablation for Persistent Atrial Fibrillation: A Prospective Randomized Trial | - |
dc.type | Article | - |
dc.identifier.pmid | 39685768 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11642079 | - |
dc.subject.keyword | atrial fibrillation | - |
dc.subject.keyword | cardiac magnetic resonance imaging | - |
dc.subject.keyword | catheter ablation | - |
dc.subject.keyword | contact force | - |
dc.subject.keyword | linear ablation | - |
dc.contributor.affiliatedAuthor | Lee, KN | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.3390/jcm13237310 | - |
dc.citation.title | Journal of clinical medicine | - |
dc.citation.volume | 13 | - |
dc.citation.number | 23 | - |
dc.citation.date | 2024 | - |
dc.citation.startPage | 7310 | - |
dc.citation.endPage | 7310 | - |
dc.identifier.bibliographicCitation | Journal of clinical medicine, 13(23). : 7310-7310, 2024 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 2077-0383 | - |
dc.relation.journalid | J020770383 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.